Monoclonal Antibodies for Autoimmune Diseases Market Estimations (2025 - 2035)

Monoclonal Antibodies for Autoimmune Diseases Market Estimations (2025 - 2035)

The monoclonal antibodies for autoimmune diseases market covers monoclonal antibodies used to treat autoimmune and immune-mediated inflammatory diseases, including interleukin inhibitors (IL-23, IL-17, IL-12/23, IL-4R, IL-6), TNF-alpha inhibitors, CD20 and B-cell antibodies, integrin and other targets, in originator and biosimilar forms, for psoriasis and psoriatic arthritis, inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, atopic dermatitis and lupus and other autoimmune diseases.

📄Report ID:2510 | 📊Format: Databook | 📅Published: 18 November 2026 | ⚡Delivery: Immediate